Predoctoral and Postdoctoral Training in Alzheimer's Pathophysiology

阿尔茨海默病病理生理学博士前和博士后培训

基本信息

  • 批准号:
    10627752
  • 负责人:
  • 金额:
    $ 34.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-01 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract We proposed creating a highly collaborative pre- and post-doctoral training program in the pathophysiology of Alzheimer’s disease and other related neoconservative disorders. Our program is dedicated on advancing pre- and post-doctoral fellows into independent research scientists at research intensive universities and health- related research laboratories. Our trainees will be mentored by members of the Mitchell Center for Neurodegenerative Diseases at the University of Texas Medical Branch – Galveston. Our highly collaborative faculty reach across multiple departments allowing them to employ a number of experimental approaches to the problems associated with Alzheimer's disease. Our training program incorporates cellular animal models, disease progression mechanisms and pharmacological manipulations, immunotherapeutic approaches targeting tau and amyloid oligomers, synaptic electrophysiology and, DNA damage and repair in neurodegeneration, genetics of synaptic development and degeneration, molecular mechanisms in cognitive resilience, and metabolic determinants of neurodegeneration. A strength of our training program is the investment UTMB has made in developing this highly collaborative team as demonstrated by our joint publications and funded grants. Our four pre-and three post-doctoral trainees will be closely mentored throughout their training. Our pre-doctoral trainees will be required to take several new courses devoted to the cellular signaling in neurodegeneration and the biochemistry and biophysics of amyloid proteins, while our post-doctoral trainees will participate in a certificate program in advanced biomedical research strategies. All trainees will participate in seminars, community building events, journal clubs and active collaborative research training. We have proposed a framework that will enable us to train and mentor both pre- and post-doctoral trainees on their way to becoming independent scientist to help address the Alzheimer’s medical needs of the country.
项目总结/文摘

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer's disease and frontotemporal dementia.
  • DOI:
    10.1016/j.celrep.2021.109419
  • 发表时间:
    2021-07-20
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Gaikwad S;Puangmalai N;Bittar A;Montalbano M;Garcia S;McAllen S;Bhatt N;Sonawane M;Sengupta U;Kayed R
  • 通讯作者:
    Kayed R
Polymorphic Alpha-Synuclein Oligomers: Characterization and Differential Detection with Novel Corresponding Antibodies.
  • DOI:
    10.1007/s12035-023-03211-3
  • 发表时间:
    2023-05
  • 期刊:
  • 影响因子:
    5.1
  • 作者:
    Moore, Kenya;Sengupta, Urmi;Puangmalai, Nicha;Bhatt, Nemil;Kayed, Rakez
  • 通讯作者:
    Kayed, Rakez
Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies.
  • DOI:
    10.1111/bpa.13112
  • 发表时间:
    2023-01
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Montalbano, Mauro;Majmundar, Lajja;Sengupta, Urmi;Fung, Leiana;Kayed, Rakez
  • 通讯作者:
    Kayed, Rakez
Microbial determinants of dementia risk in subjects of Mexican descent with type 2 diabetes living in South Texas.
生活在德克萨斯州南部的墨西哥裔 2 型糖尿病患者痴呆风险的微生物决定因素。
  • DOI:
    10.1101/2024.03.20.24304637
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Matz,LisaM;Shah,NisargS;Porterfield,Laura;Stuyck,OliviaM;Jochum,MichaelD;Kayed,Rakez;Taglialatela,Giulio;Urban,RandallJ;Buffington,ShellyA
  • 通讯作者:
    Buffington,ShellyA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rakez Kayed其他文献

Rakez Kayed的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rakez Kayed', 18)}}的其他基金

The Role of Ubiquitination in Tau Oligomers Pathogenesis
泛素化在 Tau 寡聚体发病机制中的作用
  • 批准号:
    10605268
  • 财政年份:
    2022
  • 资助金额:
    $ 34.91万
  • 项目类别:
Immunotherapy Targeting Tau Aggregate Polymorphs
针对 Tau 聚集多晶型物的免疫疗法
  • 批准号:
    10448132
  • 财政年份:
    2022
  • 资助金额:
    $ 34.91万
  • 项目类别:
Predoctoral and Postdoctoral Training in Alzheimer's Pathophysiology
阿尔茨海默病病理生理学博士前和博士后培训
  • 批准号:
    10024716
  • 财政年份:
    2021
  • 资助金额:
    $ 34.91万
  • 项目类别:
Predoctoral and Postdoctoral Training in Alzheimer's Pathophysiology
阿尔茨海默病病理生理学博士前和博士后培训
  • 批准号:
    10394187
  • 财政年份:
    2021
  • 资助金额:
    $ 34.91万
  • 项目类别:
Calcineurin Mediates the Synergistic Toxicity of Tau and Aβ Oligomers
钙调神经磷酸酶介导 Tau 和 Aβ 寡聚物的协同毒性
  • 批准号:
    9931851
  • 财政年份:
    2019
  • 资助金额:
    $ 34.91万
  • 项目类别:
Tau in the Eye and Brain
眼睛和大脑中的 Tau 蛋白
  • 批准号:
    9289398
  • 财政年份:
    2017
  • 资助金额:
    $ 34.91万
  • 项目类别:
Formation and Propagation of Tau Oligomeric Strains in Alzheimer's Disease
阿尔茨海默病中 Tau 寡聚菌株的形成和繁殖
  • 批准号:
    9903182
  • 财政年份:
    2016
  • 资助金额:
    $ 34.91万
  • 项目类别:
Formation and Propagation of Tau Oligomeric Strains in Alzheimer's Disease
阿尔茨海默病中 Tau 寡聚菌株的形成和繁殖
  • 批准号:
    10448555
  • 财政年份:
    2016
  • 资助金额:
    $ 34.91万
  • 项目类别:
Formation and Propagation of Tau Oligomeric Strains in Alzheimer's Disease
阿尔茨海默病中 Tau 寡聚菌株的形成和繁殖
  • 批准号:
    9312723
  • 财政年份:
    2016
  • 资助金额:
    $ 34.91万
  • 项目类别:
Formation and Propagation of Tau Oligomeric Strains in Alzheimer's Disease
阿尔茨海默病中 Tau 寡聚菌株的形成和繁殖
  • 批准号:
    9194258
  • 财政年份:
    2016
  • 资助金额:
    $ 34.91万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
  • 批准号:
    10657993
  • 财政年份:
    2023
  • 资助金额:
    $ 34.91万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10381163
  • 财政年份:
    2022
  • 资助金额:
    $ 34.91万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10531959
  • 财政年份:
    2022
  • 资助金额:
    $ 34.91万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10700991
  • 财政年份:
    2022
  • 资助金额:
    $ 34.91万
  • 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10518582
  • 财政年份:
    2022
  • 资助金额:
    $ 34.91万
  • 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10672973
  • 财政年份:
    2022
  • 资助金额:
    $ 34.91万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10585925
  • 财政年份:
    2022
  • 资助金额:
    $ 34.91万
  • 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
  • 批准号:
    10180000
  • 财政年份:
    2021
  • 资助金额:
    $ 34.91万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10049426
  • 财政年份:
    2021
  • 资助金额:
    $ 34.91万
  • 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
  • 批准号:
    10295809
  • 财政年份:
    2021
  • 资助金额:
    $ 34.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了